Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 8247 | 2020 |
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 6161 | 2020 |
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1325 | 2020 |
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 531 | 2021 |
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 348 | 2021 |
Mental health, physical activity, and quality of life in Parkinson’s disease during COVID-19 pandemic A Shalash, T Roushdy, M Essam, M Fathy, NL Dawood, EM Abushady, ... Mov Disord 35 (7), 1097-1099, 2020 | 177 | 2020 |
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 A Deshpande, MK Miller-Petrie, PA Lindstedt, MM Baumann, KB Johnson, ... The Lancet Global Health 8 (9), e1162-e1185, 2020 | 153 | 2020 |
Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease … RC Reiner, KE Wiens, A Deshpande, MM Baumann, PA Lindstedt, ... The Lancet 395 (10239), 1779-1801, 2020 | 123 | 2020 |
Effect of high‐frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta‐analysis C Schlenstedt, A Shalash, M Muthuraman, D Falk, K Witt, G Deuschl European journal of neurology 24 (1), 18-26, 2017 | 109 | 2017 |
Neurological events reported after COVID‐19 vaccines: an analysis of vaccine adverse event reporting system JA Frontera, AA Tamborska, MF Doheim, D Garcia‐Azorin, H Gezegen, ... Annals of Neurology 91 (6), 756-771, 2022 | 100 | 2022 |
The promise of telemedicine for movement disorders: an interdisciplinary approach H Ben-Pazi, P Browne, P Chan, E Cubo, M Guttman, A Hassan, ... Current neurology and neuroscience reports 18, 1-10, 2018 | 96 | 2018 |
Global survey on telemedicine utilization for movement disorders during the COVID‐19 pandemic A Hassan, Z Mari, EM Gatto, A Cardozo, J Youn, N Okubadejo, JA Bajwa, ... Movement Disorders 35 (10), 1701-1711, 2020 | 94 | 2020 |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 74 | 2024 |
Auditory-and vestibular-evoked potentials correlate with motor and non-motor features of Parkinson’s disease AS Shalash, DM Hassan, HH Elrassas, MM Salama, ... Frontiers in neurology 8, 55, 2017 | 69 | 2017 |
Six action steps to address global disparities in Parkinson disease: a World Health Organization priority N Schiess, R Cataldi, MS Okun, N Fothergill-Misbah, ER Dorsey, ... JAMA neurology 79 (9), 929-936, 2022 | 62 | 2022 |
Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease M Salama, M Sobh, M Emam, A Abdalla, D Sabry, M El‑Gamal, A Lotfy, ... Experimental and Therapeutic Medicine 13 (3), 976-982, 2017 | 61 | 2017 |
Global perspective on telemedicine for Parkinson’s disease A Shalash, M Spindler, E Cubo Journal of Parkinson's Disease 11 (s1), S11-S18, 2021 | 58 | 2021 |
Elevated serum α-synuclein autoantibodies in patients with parkinson’s disease relative to Alzheimer’s disease and controls A Shalash, M Salama, M Makar, T Roushdy, HH Elrassas, W Mohamed, ... Frontiers in Neurology 8, 720, 2017 | 58 | 2017 |
The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus A Shalash, A Alexoudi, K Knudsen, J Volkmann, M Mehdorn, G Deuschl Parkinsonism & related disorders 20 (1), 47-52, 2014 | 56 | 2014 |
Non-motor symptoms as predictors of quality of life in Egyptian patients with Parkinson’s disease: a cross-sectional study using a culturally adapted 39-item Parkinson’s … AS Shalash, E Hamid, HH Elrassas, AS Bedair, AI Abushouk, M Khamis, ... Frontiers in neurology 9, 357, 2018 | 46 | 2018 |